IMAGE IN CARDIOLOGY

DOI: 10.4244/EIJV11I1A16

Severe intraventricular dynamic gradient following transcatheter aortic valve implantation: suicide ventricle?

Fernando Alfonso1*, MD; Lourdes Domínguez1, MD; Fernando Rivero1, MD; Amparo Benedicto1, MD; Ramiro Trillo2, MD

A 79-year-old woman with severe aortic stenosis and progressive dyspnoea was referred to our centre for transcatheter aortic valve implantation (TAVI). An echocardiogram revealed normal left ventricular function with concentric left ventricular hypertrophy and severe, heavily calcified, aortic stenosis (mean gradient 82 mmHg; valve area 0.85 cm2). On cardiac catheterisation a “peak-to-peak” aortic valve gradient of 97 mmHg was demonstrated (Figure 1A), and a 26 mm CoreValve® (Medtronic, Minneapolis, MN, USA) was successfully implanted. However, immediately after the intervention, a severe intraventricular gradient was found (Figure 1B). As this gradient completely disappeared at the valvular level (Figure 1C), it was interpreted as catheter entrapment in the setting of hypovolaemia and transient haemodynamic instability. A transoesophageal echocardiogram confirmed a normal function of the CoreValve (Figure 1D [arrows], Moving Image 1) but, unexpectedly, disclosed complete systolic obliteration of the left ventricular cavity (Moving image 2, Moving image 3) causing major obstruction (turbulent flow) at the mid ventricular level and outflow tract (Figure 1E, Moving image 4). The characteristic morphology of a “dynamic” intraventricular gradient (120 mmHg), with a “late peaking” pattern (curved arrows) identical to that previously elicited in the haemodynamic suite, was readily depicted (Figure 1F). No significant systolic anterior motion of the mitral valve was found. The patient remained asymptomatic and eventually she was discharged seven days later with a persisting dynamic intraventricular gradient (90 mmHg) despite increasing doses of beta-blockers.

Figure 1. Top: Pressure tracings. Bottom: Echocardiographic and Doppler findings. A) Aortic and left ventricular pressures before TAVI. B) Aortic and left ventricular pressures immediately after TAVI. Notice the late-peaking intraventricular gradient. C) Absence of gradient at the aortic valve level. D) Transoesophageal echocardiogram showing the implanted valve (yellow arrows). E) Turbulent flow in the left ventricular outflow tract. F) Dynamic intraventricular gradient on continuous wave Doppler. LA: left atrium; LV: left ventricle

Our findings demonstrate that severe intraventricular dynamic gradients may emerge after TAVI. The pathophysiology of this phenomenon appears to be similar to that typically described in the postoperative period of rare patients following surgical aortic valve replacement.

Conflict of interest statement

R. Trillo is proctor for the Medtronic CoreValve. The other authors have no conflicts of interest to declare.

Online data supplement

Moving image 1. Transoesophageal echocardiography revealing a normal function of the aortic valve after TAVI.

Moving image 2. Transgastric longitudinal view of the left ventricle disclosing the left ventricular hypertrophy and systolic cavity obliteration after TAVI.

Moving image 3. Transgastric short-axis view of the left ventricle showing similar findings.

Moving image 4. Colour Doppler depicting the intraventricular turbulent flow after TAVI.

Supplementary data

To read the full content of this article, please download the PDF.

Moving image 1. Transoesophageal echocardiography revealing a normal function of the aortic valve after TAVI.

Moving image 2. Transgastric longitudinal view of the left ventricle disclosing the left ventricular hypertrophy and systolic cavity obliteration after TAVI.

Moving image 3. Transgastric short-axis view of the left ventricle showing similar findings.

Moving image 4. Colour Doppler depicting the intraventricular turbulent flow after TAVI.

Volume 11 Number 1
May 19, 2015
Volume 11 Number 1
View full issue


Key metrics

Suggested by Cory

Editorial

10.4244/EIJ-E-24-00065 Apr 21, 2025
From invasive gradients to pressure recovery: rethinking long-standing paradigms
Joner M and Mylotte D
free

10.4244/EIJV7I5A99 Sep 30, 2011
Complications of transcatheter aortic valve implantation: avoidance and management
Hildick-Smith D et al
free

Editorial

10.4244/EIJ-E-23-00068 Mar 4, 2024
Acute changes in microvascular resistance after treating aortic stenosis
Johnson N and Eerdekens R
free

IMAGE IN CARDIOLOGY

10.4244/EIJV12I7A151 Sep 18, 2016
Transcatheter aortic valve implantation: the importance of an experienced multidisciplinary team
Lopez-Lluva M et al
free

State-of-the-Art

10.4244/EIJ-D-24-00066 Apr 21, 2025
Management of complications after valvular interventions
Bansal A et al
free
Trending articles
166.7

Expert review

10.4244/EIJ-D-21-00690 May 15, 2022
Crush techniques for percutaneous coronary intervention of bifurcation lesions
Moroni F et al
free
92.45

State-of-the-Art Review

10.4244/EIJ-D-20-01296 Aug 27, 2021
Management of cardiogenic shock
Thiele H et al
free
72.95

State-of-the-Art

10.4244/EIJ-D-24-00386 Feb 3, 2025
Mechanical circulatory support for complex, high-risk percutaneous coronary intervention
Ferro E et al
free
60.55

State-of-the-Art

10.4244/EIJ-D-24-00066 Apr 21, 2025
Management of complications after valvular interventions
Bansal A et al
free
58.3

Clinical research

10.4244/EIJ-D-23-00344 Sep 18, 2023
Clinical outcomes of TAVI with the Myval balloon-expandable valve for non-calcified aortic regurgitation
Sanchez-Luna JP et al
free
33.9

CLINICAL RESEARCH

10.4244/EIJ-D-17-00381 Oct 11, 2017
Stent malapposition and the risk of stent thrombosis: mechanistic insights from an in vitro model
Foin N et al
free
33.65

State-of-the-Art

10.4244/EIJ-D-23-00606 Jan 1, 2024
Targeting inflammation in atherosclerosis: overview, strategy and directions
Waksman R et al
free
26

Expert Review

10.4244/EIJ-D-24-00535 May 5, 2025
Catheter-based techniques for pulmonary embolism treatment
Costa F et al
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved